Who is sponsoring NCT02196740?

NCT02196740 is sponsored by Lin Jiacheng.

What drugs are being tested in NCT02196740?

Interventions in NCT02196740: Metronidazole-Ciprofloxacin gatifloxacin-Clindamycin paste, creosote.

What condition does NCT02196740 study?

NCT02196740 studies Periapical Diseases.

Is NCT02196740 still recruiting?

NCT02196740 is currently status unknown. Last updated 21 July 2014.

Last reviewed 2014-07-21 · How we verify

NCT02196740

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Randomized Controlled Research of the Application of Triple Antibiotic Paste in Primary Teeth With

Status unknown NA Last updated 21 July 2014

What this trial tests

NA trial testing Metronidazole-Ciprofloxacin gatifloxacin-Clindamycin paste in Periapical Diseases in 100 participants. Status unknown.

Timeline

1 June 2013

Primary endpoint
1 December 2014

1 June 2015

Quick facts

Lead sponsor	Lin Jiacheng
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	100
Start date	1 June 2013
Primary completion	1 December 2014
Estimated completion	1 June 2015
Sites	1 location across China

Drugs / interventions tested

Metronidazole-Ciprofloxacin gatifloxacin-Clindamycin paste — full drug profile →
creosote (creosote) — full drug profile →

Conditions studied

Periapical Diseases — all drugs for Periapical Diseases →

Sponsor

Lin Jiacheng — full company profile →

Who can join

Adults 3 to 8, any sex, with Periapical Diseases. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Evidence of lesion healing confirmed by cone beam computed tomography and X-rays
Time frame: 1 year

Sponsor's own description

The triple antibiotic paste is widely used in young permanent teeth and permanent teeth root canal therapy with excellent antiantimicrobial effect.We hypothesize that its application in the treatment of periapical periodontitis of deciduous teeth is superior to other drugs currently in use as creosote.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Periapical Diseases

Currently open trials in the same condition.

NCT07448571 — Evaluation of Revitalization Success Using i-PRF in Non-Surgical Root Canal Retreatment · NA · recruiting
NCT06643663 — Role of GTR on Healing Outcome & Quality of Life in Combined Endo Perio Lesions With Communication · NA · recruiting
NCT06252337 — Survival and Success of Two Different Filling Techniques · NA · active not recruiting
NCT05888935 — Detection of Periapical Lesions on Dental Panoramic Radiographs Based on Artificial Intelligence · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02196740 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lin Jiacheng
Last refreshed: 21 July 2014

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02196740.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing